B
Eli Lilly and Company LLY
$877.29 -$7.25-0.82% NYSE
Recommendation
Prev Close
$884.54
Volume
3,453,114
Avg Vol (90D)
3,706,862
Market Cap
$794.31B
Dividend & Yield
$5.40(0.61%)
52-Week Range
$677.09 - $972.53
P/E (TTM)
75.52
EPS (TTM)
$11.71
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Eli Lilly Nails Oral GLP-1 Trial—Here’s What It Means for LLY
4/23/2025 - MarketBeat
Eli Lilly: Why Orforglipron Matters, A Lot
4/28/2025 - SeekingAlpha
Eli Lilly: Why Orforglipron Matters, A Lot
4/28/2025 - Seeking Alpha - Long Ideas
Boeing Upgraded, eyes taking over supplier Spirit AeroSystems
4/28/2025 - Bloomberg Markets and Finance-YouTube
Eli Lilly and Company (NYSE:LLY) Shares Down 1.1% - Here's What Happened
4/28/2025 - Ticker Report
Top Pharmaceutical Stocks To Keep An Eye On - April 27th
4/28/2025 - MarketBeat
Medical Stocks To Watch Today - April 26th
4/28/2025 - MarketBeat
Calls of the Day: Eli Lilly
4/28/2025 - CNBC Television-YouTube
IBM plans to invest $150 billion in US over next five years
4/28/2025 - The Mercury News: Business and Tech
IBM plans to invest $150 billion in US over next five years
4/28/2025 - SiliconValley.com
PepsiCo CEO was grilled about GLP-1s by a 13-year-old on his Q1 conference call
4/28/2025 - Fortune
Will These 5 Big Drug Stocks Surpass Q1 Earnings Forecasts?
4/28/2025 - Zacks Investment Research
Is Eli Lilly Stock a Portfolio Must-Have Pre-Q1 Earnings? (Revised)
4/28/2025 - Zacks Investment Research
Eli Lilly Stock Moves Lower on Rare Double Downgrade
4/28/2025 - Schaeffers Research: News & Analysis
BA Soars on Upgrade, LLY Double Downgrade, DPZ Earnings Slide
4/28/2025 - Schwab Network
Eli Lilly Stock Gets A Double Downgrade And Price Target Cut By HSBC Over Valuation, Competition Concerns
4/28/2025 - Stocktwits News Feed
Eli Lilly, Pfizer Risk Billions in Losses From Trump's 25% Pharma Tariffs
4/28/2025 - GuruFocus
Video: S&P 500 Movers: NVDA, NCLH
4/28/2025 - Market News Video
Northern Trust Corp Grows Position in Eli Lilly and Company (NYSE:LLY)
4/28/2025 - Ticker Report
Capstone Financial Advisors Inc. Reduces Holdings in Eli Lilly and Company (NYSE:LLY)
4/28/2025 - Ticker Report
US stocks open mostly flat: Nasdaq down 0.1%, Dow jumps 179 points
4/28/2025 - Invezz News
Live Nasdaq Composite: Markets Attempt Gains in Mag-7 Earnings Week
4/28/2025 - 24/7 Wall St.
Key Events This Week: Peak Earnings Season, Canada Election, Payrolls, PCE, GDP... And Trade War Goes On
4/28/2025 - Zero Hedge
Eli Lilly and Company (NYSE:LLY) Shares Acquired by Beacon Pointe Advisors LLC
4/28/2025 - Ticker Report
Viking Therapeutics Stock Pops But Struggles to Hold Gains
4/16/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$45.04B
EBITDA (TTM)
$19.27B
EBIT (TTM)
$17.50B
Net Income (TTM)
$10.59B
Balance Sheet
Total Assets (Q)
$78.71B
Total Debt (Q)
$34.91B
Total Liabilities (Q)
$64.44B
Book Value Per Share (Q)
$15.81
Cash Flow
Cash from Operations (TTM)
$8.82B
Cash from Investing (TTM)
-$9.30B
Cash from Financing (TTM)
$1.23B
Net Change in Cash (TTM)
$449.80M
Filings
Filing Date
Wednesday, February 19, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
End of April (est)
Price History
Loading...
Beta
0.95
7-Day Total Return
19.38%
30-Day Total Return
7.84%
60-Day Total Return
6.75%
90-Day Total Return
11.36%
Year to Date Total Return
12.94%
1-Year Total Return
20.38%
2-Year Total Return
136.63%
3-Year Total Return
218.82%
5-Year Total Return
478.33%
52-week Low
Apr 07, 2025 - $677.09
52-week High
Aug 22, 2024 - $972.53
Valuation
Market Cap
$794.31B - Mega Cap
Enterprise Value
$825.38B
Price/Sales (TTM)
17.74
Price/Book (Q)
55.94
Dividends and Shares
Shares Outstanding
903.16M
Dividend Per Share (Most Recent)
$1.50
Dividend Per Share (TTM)
$5.40
Corporate Info
Website
www.lilly.com
Phone Number
317 276 2000
Address
Lilly Corporate Center
Indianapolis, IN 46285
Country
United States
Year Founded
1876
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix... more
NYSE 04/28/2025 4:00PM Eastern Quotes delayed